Nirsevimab Against Hospitalizations and Emergency Department Visits for Lower Respiratory Tract Infection in Infants

In this meta-analysis, nirsevimab was associated with reduced LRTI-related hospitalizations and ED visits in infants and young children. These findings support nirsevimab's potential to reduce respiratory-related morbidity in young children and health care utilization.